论文部分内容阅读
目的:探讨原发性肝癌介入治疗的临床疗效。方法:对照组36例给予经肝动脉栓塞化疗(TA-CE)治疗,实验组38例给予经肝动脉栓塞化疗(TACE)+超声引导微波凝固(PMCT)介入治疗,对比分析两组患者的临床疗效。结果:对照组、实验组总有效率分别为66.67%、92.11%,实验组总有效率明显高于对照组,两组差异有统计学意义(P<0.05)。结论:对原发性肝癌患者给予TACE+PMCT介入治疗,可提高临床疗效,促进疾病治疗。
Objective: To investigate the clinical effect of interventional therapy of primary liver cancer. Methods: Thirty-six patients in the control group were treated with TA-CE and 38 in the experimental group were treated with TACE plus ultrasound-guided microwave coagulation (PMCT). The clinical data of two groups were compared Efficacy. Results: The total effective rate of the control group and the experimental group was 66.67% and 92.11%, respectively. The total effective rate of the experimental group was significantly higher than that of the control group (P <0.05). Conclusion: Interventional treatment with TACE + PMCT in patients with primary liver cancer can improve clinical efficacy and promote disease treatment.